Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies

Cellular and Molecular Life Sciences

Volumn 64, Issue 15, 2007, Pages 2023-2041

  Holtkamp, M ^a   Meierkord, H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Epileptogenesis; Established epilepsy; GABAergic inhibition; Glutamatergic system; Ictogenesis; Ion channels; Status epilepticus

Indexed keywords

ACETYLCHOLINE; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; DIAZEPAM; DIZOCILPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; GLYCINE; IONOTROPIC RECEPTOR; KETAMINE; LAMOTRIGINE; LORAZEPAM; MONOAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; ZONISAMIDE;

ANTICONVULSANT ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GABAERGIC SYSTEM; HUMAN; LIMBIC CORTEX; MOLECULAR DYNAMICS; MONOTHERAPY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SEIZURE; SINGLE DRUG DOSE;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNELS; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; RECEPTORS, GABA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHANNELS; STATUS EPILEPTICUS;

ANIMALIA;

EID: 34447625945     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7021-2     Document Type: Review

References (243)

1. Chen, J. W. and Wasterlain, C. G. (2006) Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 5, 246-256.
2. McNamara, J. O., Huang, Y. Z. and Leonard, A. S. (2006) Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE. re12.
3. Pitkanen, A. (2002) Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology 59 Suppl. 5, S27-S33.
4. Rogawski, M. A. and Loscher, W. (2004) The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5, 553-564.
5. Pitkanen, A. and Kubova, H. (2004) Antiepileptic drugs in neuroprotection. Expert. Opin. Pharmacother. 5, 777-798.
6. Rogawski, M. A. and Loscher, W. (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat. Med. 10, 685-692.
7. Kaindl, A. M., Asimiadou, S., Manthey, D., Hagen, M. V., Turski, L. and Ikonomidou, C. (2006) Antiepileptic drugs and the developing brain. Cell Mol. Life Sci. 63, 399-413.
8. Catterall, W. A. (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 6, 13-25.
9. McLean, M. J., Schmutz, M., Wamil, A. W., Olpe, H. R., Portet, C. and Feldmann, K. F. (1994) Oxcarbazepine: mechanisms of action. Epilepsia 35 Suppl. 3, S5-S9.
10. McLean, M. J. and Macdonald, R. L. (1983) Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 227, 779-789.
11. Taglialatela, M., Ongini, E., Brown, A. M., Di Renzo, G. and Annunziato, L. (1996) Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain. Eur. J. Pharmacol. 316, 373-377.
12. Taverna, S., Sancini, G., Mantegazza, M., Franceschetti, S. and Avanzini, G. (1999) Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J. Pharmacol. Exp. Ther. 288, 960-968.
13. Albus, H. and Williamson, R. (1998) Electrophysiologic analysis of the actions of valproate on pyramidal neurons in the rat hippocampal slice. Epilepsia 39, 124-139.
14. Schauf, C. L. (1987) Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res. 413, 185-188.
15. Macdonald, R. L. and Kelly, K. M. (1995) Antiepileptic drug mechanisms of action. Epilepsia 36 Suppl. 2, S2-S12.
16. Kuo, C. C. (1998) A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels. Mol. Pharmacol. 54, 712-721.
17. Backus, K. H., Pflimlin, P. and Trube, G. (1991) Action of diazepam on the voltage-dependent Na+ current. Comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil. Brain Res. 548, 41-49.
18. Kendig, J. J. (1981) Barbiturates: active form and site of action at node of Ranvier sodium channels. J. Pharmacol. Exp. Ther. 218, 175-181.
19. Martella, G., De Persis, C., Bonsi, P., Natoli, S., Cuomo, D., Bernardi, G., Calabresi, P. and Pisani, A. (2005) Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: implications for its antiepileptic activity. Epilepsia 46, 624-635.
20. Catterall, W. A. (2000) Structure and regulation of voltage-gated Ca2+channels. Annu. Rev Cell Dev. Biol. 16, 521-555.
21. van Luijtelaar, E. L., Ates, N. and Coenen, A. M. (1995) Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats. Epilepsia 36, 86-92.
22. Tanabe, M., Gahwiler, B. H. and Gerber, U. (1998) L-Type Ca2+ channels mediate the slow Ca2+-dependent after-hyperpolarization current in rat CA3 pyramidal cells in vitro. J. Neurophysiol. 80, 2268-2273.
23. Ambrosio, A. F., Silva, A. P., Malva, J. O., Soares-da-Silva, P., Carvalho, A. P. and Carvalho, C. M. (1999) Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 38, 1349-1359.
24. Elliott, E. M., Malouf, A. T. and Catterall, W. A. (1995) Role of calcium channel subtypes in calcium transients in hippocampal CA3 neurons. J. Neurosci. 15, 6433-6444.
25. Turner, T. J. (1998) Calcium channels coupled to glutamate release. Prog. Brain Res. 116, 3-14.
26. Stefani, A., Spadoni, F., Siniscalchi, A. and Bernardi, G. (1996) Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur. J. Pharmacol. 307, 113-116.
27. Lukyanetz, E. A., Shkryl, V. M. and Kostyuk, P. G. (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43, 9-18.
28. Niespodziany, I., Klitgaard, H. and Margineanu, D. G. (2001) Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci. Lett. 306, 5-8.
29. Zhang, X., Velumian, A. A., Jones, O. T. and Carlen, P. L. (2000) Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41 Suppl. 1, S52-S60.
30. Gee, N. S., Brown, J. P., Dissanayake, V. U., Offord, J., Thurlow, R. and Woodruff, G. N. (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2-delta subunit of a calcium channel. J. Biol. Chem. 271, 5768-5776.
31. Marais, E., Klugbauer, N. and Hofmann, F. (2001) Calcium channel alpha(2)delta subunits-structure and Gabapentin binding. Mol. Pharmacol. 59, 1243-1248.
32. Fink, K., Meder, W., Dooley, D. J. and Gothert, M. (2000) Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br. J. Pharmacol. 130, 900-906.
33. McCormick, D. A. and Contreras, D. (2001) On the cellular and network bases of epileptic seizures. Annu. Rev. Physiol. 63, 815-846.
34. Huguenard, J. R. (1996) Low-threshold calcium currents in central nervous system neurons. Annu. Rev. Physiol. 58, 329-348.
35. Gloor, P. and Fariello, R. G. (1988) Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci. 11, 63-68.
36. Coulter, D. A., Huguenard, J. R. and Prince, D. A. (1989) Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann. Neurol 25, 582-593.
37. Gomora, J. C., Daud, A. N., Weiergraber, M. and Perez-Reyes, E. (2001) Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol. Pharmacol. 60, 1121-1132.
38. Kito, M., Maehara, M. and Watanabe, K. (1996) Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 5, 115-119.
39. Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A. and Fuks, B. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci., USA 101, 9861-9866.
40. Cossart, R., Bernard, C. and Ben Ari, Y. (2005) Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci. 28, 108-115.
41. Rogers, C. J., Twyman, R. E. and Macdonald, R. L. (1994) Benzodiazepine and beta-carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture. J. Physiol. 475, 69-82.
42. Walker, M. C. and Fisher, A. (2004) Mechanisms of antiepileptic drug action. In: The Treatment of Epilepsy, pp. 96-119, Shorvon, S., Perucca, E., Fish, D. and Dodson, E. (eds.), Blackwell Publishing, Oxford.
43. Bernard, C. (2005) Dogma and dreams: experimental lessons for epilepsy mechanism chasers. Cell. Mol. Life Sci. 62, 1177-1181.
44. Szabadics, J., Varga, C., Molnar, G., Olah, S., Barzo, P. and Tamas, G. (2006) Excitatory effect of GABAergic axoaxonic cells in cortical microcircuits. Science 311, 233-235.
45. Cohen, I., Navarro, V., Clemenceau, S., Baulac, M. and Miles, R. (2002) On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298, 1418-1421.
46. McIntyre, D. C. and Gilby, K. L. (2006) Parahippocampal networks, intractability, and the chronic epilepsy of kindling. Adv. Neurol. 97, 77-83.
47. Racine, R. J., Steingart, M. and McIntyre, D. C. (1999) Development of kindling-prone and kindling-resistant rats: selective breeding and electrophysiological studies. Epilepsy Res. 35, 183-195.
48. Golden, G. T., Smith, G. G., Ferraro, T. N. and Reyes, P. F. (1995) Rat strain and age differences in kainic acid induced seizures. Epilepsy Res. 20, 151-159.
49. Meierkord, H., Grunig, F., Gutschmidt, U., Gutierrez, R., Pfeiffer, M., Draguhn, A., Bruckner, C. and Heinemann, U. (2000) Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition. Naunyn Schmiedebergs Arch. Pharmacol. 361, 25-32.
50. Haefely, W. (1990) Benzodiazepine receptor and ligands: structural and functional differences. In: Benzodiazepines: Current Concepts, pp. 1-18, Hindmarch, I., Beaumont, G., Brandon, S. and Leonard, B. E. (eds.), John Wiley & Sons, Chichester, U.K.
51. Macdonald, R. L. (1983) Mechanisms of anticonvulsant drug action. In: Recent Advances in Epilepsy I, pp. 1-23, Pedley, T. A. and Meldrum, B. S. (eds.), Churchill Livingstone, Edinburgh.
52. Barker, J. and Owen, D. G. (1986) Electrophysiological pharmacology of GABA and diazepam in cultured CNS neurons. In: Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties, pp. 135-165, Olsen, R. W. and Venter, J. C. (eds.), Alan R. Liss, New York.
53. Macdonald, R. L. and Olsen, R. W. (1994) GABAA receptor channels. Annu. Rev. Neurosci. 17, 569-602.
54. Study, R. E. and Barker, J. L. (1981) Diazepam and ( -)- pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. USA 78, 7180-7184.
55. Twyman, R. E., Rogers, C. J. and Macdonald, R. L. (1989) Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann. Neurol. 25, 213-220.
56. Hara, M., Kai, Y. and Ikemoto, Y. (1993) Propofol activates GABAA receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 79, 781-788.
57. Adodra, S. and Hales, T. G. (1995) Potentiation, activation and blockade of GABAA receptors of clonal murine hypothalamic GT1 - 7 neurones by propofol. Br. J. Pharmacol. 115, 953-960.
58. Orser, B. A., Wang, L. Y., Pennefather, P. S. and MacDonald, J. F. (1994) Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons. J. Neurosci. 14, 7747-7760.
59. Hara, M., Kai, Y. and Ikemoto, Y. (1994) Enhancement by propofol of the gamma-aminobutyric acidA response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 81, 988-994.
60. Rho, J. M., Donevan, S. D. and Rogawski, M. A. (1997) Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J. Pharmacol. Exp. Ther. 280, 1383-1391.
61. White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A. and Wolf, H. H. (1997) Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 28, 167-179.
62. Loscher, W., Honack, D. and Taylor, C. P. (1991) Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci. Lett. 128, 150-154.
63. Loscher, W. (1982) Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice. Biochem. Pharmacol. 31, 837-842.
64. Loscher, W. and Horstermann, D. (1994) Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn Schmiedebergs Arch. Pharmacol. 349, 270-278.
65. Sarup, A., Larsson, O. M. and Schousboe, A. (2003) GABA transporters and GABA-transaminase as drug targets. Curr. Drug Targets CNS Neurol. Disord. 2, 269-277.
66. Suzdak, P. D. and Jansen, J. A. (1995) A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36, 612-626.
67. Couve, A., Moss, S. J. and Pangalos, M. N. (2000) GABAB receptors: a new paradigm in G protein signaling. Mol. Cell. Neurosci. 16, 296-312.
68. Mott, D. D. and Lewis, D. V. (1994) The pharmacology and function of central GABAB receptors. Int. Rev Neurobiol. 36, 97-223.
69. Schuler, V., Luscher, C., Blanchet, C., Klix, N., Sansig, G., Klebs, K., Schmutz, M., Heid, J., Gentry, C., Urban, L. et al. (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 31, 47-58.
70. von Krosigk, M., Bal, T. and McCormick, D. A. (1993) Cellular mechanisms of a synchronized oscillation in the thalamus. Science 261, 361-364.
71. Dingledine, R., Borges, K., Bowie, D. and Traynelis, S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
72. Bertram, E. H. and Lothman, E. W. (1990) NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants. Epilepsy Res. 5, 177-184.
73. Fujikawa, D. G., Daniels, A. H. and Kim, J. S. (1994) The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res. 17, 207-219.
74. Rice, A. C. and DeLorenzo, R. J. (1998) NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 782, 240-247.
75. Lerner-Natoli, M., Rondouin, G., Belaidi, M., Baldy-Moulinier, M. and Kamenka, J., M. (1991) N-[1-(2-thienyl)cyclohexyl]-piperidine (TCP) does not block kainic acid-induced status epilepticus but reduces secondary hippocampal damage. Neurosci. Lett. 122, 174-178.
76. Fujikawa, D. G. (1995) Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36, 186-195.
77. Wong, E. H., Kemp, J. A., Priestley, T., Knight, A. R., Woodruff, G. N. and Iversen, L. L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.SA 83, 7104-7108.
78. Kuo, C. C., Lin, B., J., Chang, H. R. and Hsieh, C. P. (2004) Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels. Mol. Pharmacol. 65, 370-380.
79. Yamakura, T., Mori, H., Masaki, H., Shimoji, K. and Mishina, M. (1993) Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. Neuroreport 4, 687-690.
80. Bleakman, D. (1999) Kainate receptor pharmacology and physiology. Cell Mol. Life Sci. 56, 558-566.
81. Gibbs, J. W., III, Sombati, S., DeLorenzo, R. J. and Coulter, D. A. (2000) Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 Suppl. 1, S10-S16.
82. Gryder, D. S. and Rogawski, M. A. (2003) Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J. Neurosci. 23, 7069-7074.
83. Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E. and Tomson, T. (2007) Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res. 73, 1-52.
84. McCloskey, D. P., Croll, S. D. and Scharfman, H. E. (2005) Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J. Neurosci. 25, 8889-8897.
85. Vezzani, A. and Granata, T. (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46, 1724-1743.
86. Vezzani, A., Conti, M., De Luigi, A., Ravizza, T., Moneta, D., Marchesi, F. and De Simoni, M. G. (1999) Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19, 5054-5065.
87. Matoth, I., Pinto, F., Sicsic, C. and Brenner, T. (2000) Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells. Neurosci. Res. 38, 209-212.
88. Ichiyama, T., Okada, K., Lipton, J. M., Matsubara, T., Hayashi, T. and Furukawa, S. (2000) Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 857, 246-251.
89. Theodore, W. H., Porter, R. J., Albert, P., Kelley, K., Bromfield, E., Devinsky, O. and Sato, S. (1994) The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 44, 1403-1407.
90. Meierkord, H., Boon, P., Engelsen, B., Gocke, K., Shorvon, S., Tinuper, P. and Holtkamp, M. (2006) EFNS guideline on the management of status epilepticus. Eur. J. Neurol 13, 445-450.
91. DeLorenzo, R. J., Garnett, L. K., Towne, A. R., Waterhouse, E. J., Boggs, J. G., Morton, L., Choudhry, M. A., Barnes, T. and Ko, D. (1999) Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 40, 164-169.
92. Lowenstein, D. H., Bleck, T. and Macdonald, R. L. (1999) Its time to revise the definition of status epilepticus. Epilepsia 40, 120-122.
93. Coeytaux, A., Jallon, P., Galobardes, B. and Morabia, A. (2000) Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 55, 693-697.
94. DeLorenzo, R. J., Hauser, W. A., Towne, A. R., Boggs, J. G., Pellock, J. M., Penberthy, L., Garnett, L., Fortner, C. A. and Ko, D. (1996)Aprospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46, 1029-1035.
95. Lowenstein, D. H. and Alldredge, B. K. (1998) Status epilepticus. N. Engl. J. Med. 338, 970-976.
96. Meierkord, H. and Holtkamp, M. (2007) Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 6, 329-339.
97. Mayer, S. A., Claassen, J., Lokin, J., Mendelsohn, F., Dennis, L. J. and Fitzsimmons, B. F. (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch. Neurol. 59, 205-210.
98. Holtkamp, M., Othman, J., Buchheim, K. and Meierkord, H. (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J. Neurol. Neurosurg. Psychiatry 76, 534-539.
99. Rossetti, A. O., Logroscino, G. and Bromfield, E. B. (2005) Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch. Neurol. 62, 1698-1702.
100. Treiman, D. M., Meyers, P. D., Walton, N. Y., Collins, J. F., Colling, C., Rowan, A. J., Handforth, A., Faught, E., Calabrese, V. P., Uthman, B. M., et al. (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. Med. 339, 792-798.
101. Macdonald, R., L. and Kapur, J. (2006) Role of GABAA receptors in status epilepticus. In: Status Epilepticus-Mechanisms and Management, pp. 267-280, Wasterlain, C. G. and Treiman, D. M. (eds.), The MIT Press, Cambridge, MA.
102. Naylor, D. E. and Wasterlain, C. G. (2005) GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation. Epilepsia 46 Suppl. 5, 142-147.
103. Naylor, D. E., Liu, H. and Wasterlain, C. G. (2005)Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J. Neurosci. 25, 7724-7733.
104. Mazarati, A. M., Baldwin, R. A., Sankar, R. and Wasterlain, C. G. (1998) Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 814, 179-185.
105. Kapur, J. and Macdonald, R. L. (1997) Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci. 17, 7532-7540.
106. Kaila, K. and Voipio, J. (1987) Postsynaptic fall in intracellular pH induced by GABA-activated bicarbonate conductance. Nature 330, 163-165.
107. Staley, K. J., Soldo, B. L. and Proctor, W. R. (1995) Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269, 977-981.
108. Wasterlain, C. G., Liu, H., Mazarati, A. and Baldwin, R. (2002) NMDA receptor trafficking during the transition from single seizures to status epilepticus. Ann. Neurol. 52 Suppl. 1, 16 (abstract).
109. Ramsay, R. E., Hammond, E. J., Perchalski, R. J. and Wilder, B. J. (1979) Brain uptake of phenytoin, phenobarbital, and diazepam. Arch. Neurol. 36, 535-539.
110. Arendt, R. M., Greenblatt, D. J., deJong, R. H., Bonin, J. D., Abernethy, D. R., Ehrenberg, B. L., Giles, H. G., Sellers, E. M. and Shader, R. I. (1983) In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J. Pharmacol. Exp. Ther. 227, 98-106.
111. Cock, H. R. and Schapira, A. H. (2002) A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM 95, 225-231.
112. Shorvon, S. (1994) Status Epilepticus: Its Clinical Features and Treatment in Children and Adults, Cambridge University Press, Cambridge.
113. Turcant, A., Delhumeau, A., Premel-Cabic, A., Granry, J. C., Cottineau, C., Six, P. and Allain, P. (1985) Thiopental pharmacokinetics under conditions of long-term infusion. Anesthesiology 63, 50-54.
114. Wessen, A., Persson, P. M., Nilsson, A. and Hartvig, P. (1994) Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade. J. Clin. Anesth. 6, 193-198.
115. Lowenstein, D. H. and Alldredge, B. K. (1993) Status epilepticus at an urban public hospital in the 1980s. Neurology 43, 483-488.
116. Alldredge, B. K., Gelb, A. M., Isaacs, S. M., Corry, M. D., Allen, F., Ulrich, S., Gottwald, M. D., O'Neil, N., Neuhaus, J. M., Segal, M. R. et al. (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N. Engl. J. Med. 345, 631-637.
117. Claassen, J., Hirsch, L. J., Emerson, R. G. and Mayer, S. A. (2002) Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 43, 146-153.
118. Ropper, A. H. (2003) Neurological and Neurosurgical Intensive Care, Lippincott Williams & Wilkins, Boston.
119. Towne, A. R., Garnett, L. K., Waterhouse, E. J., Morton, L. D. and DeLorenzo, R. J. (2003) The use of topiramate in refractory status epilepticus. Neurology 60, 332-334.
120. Bensalem, M. K. and Fakhoury, T. A. (2003) Topiramate and status epilepticus: report of three cases. Epilepsy Behav. 4, 757-760.
121. Reuber, M., Evans, J. and Bamford, J. M. (2002) Topiramate in drug-resistant complex partial status epilepticus. Eur. J. Neurol. 9, 111-112.
122. Patel, N. C., Landan, I. R., Levin, J., Szaflarski, J. and Wilner, A. N. (2006) The use of levetiracetam in refractory status epilepticus. Seizure. 15, 137-141.
123. Rossetti, A. O. and Bromfield, E. B. (2006) Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav. 8, 651-654.
124. Borris, D. J., Bertram, E. H. and Kapur, J. (2000) Ketamine controls prolonged status epilepticus. Epilepsy Res. 42, 117-122.
125. Prasad, A., Williamson, J. M. and Bertram, E. H. (2002) Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann. Neurol. 51, 175-181.
126. Sheth, R. D. and Gidal, B. E. (1998) Refractory status epilepticus: response to ketamine. Neurology 51, 1765-1766.
127. Bleck, T., Quigg, M., Nathan, B. R., Smith, T. L. and Kapur, J. (2002) Electroencephalographic effects of ketamine treatment for refractory status epilepticus. Epilepsia 43 Suppl. 7, 282. 2002 (abstract).
128. Ubogu, E. E., Sagar, S. M., Lerner, A. J., Maddux, B. N., Suarez, J. I. and Werz, M. A. (2003) Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav. 4, 70-75.
129. Annegers, J. F., Hauser, W. A., Coan, S. P. and Rocca, W. A. (1998) A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 338, 20-24.
130. Asikainen, I., Kaste, M. and Sarna, S. (1999) Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia 40, 584-589.
131. Jennett, W. B. and Lewin, W. (1960) Traumatic epilepsy after closed head injuries. J. Neurol. Neurosurg. Psychiatry 23, 295-301.
132. Salazar, A. M., Jabbari, B., Vance, S. C., Grafman, J., Amin, D. and Dillon, J. D. (1985) Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 35, 1406-1414.
133. Caveness, W. F., Meirowsky, A. M., Rish, B. L., Mohr, J. P., Kistler, J. P., Dillon, J. D. and Weiss, G. H. (1979) The nature of posttraumatic epilepsy. J. Neurosurg. 50, 545-553.
134. Lamy, C., Domigo, V., Semah, F., Arquizan, C., Trystram, D., Coste, J. and Mas, J. L. (2003) Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 60, 400-404.
135. Bladin, C. F., Alexandrov, A. V., Bellavance, A., Bornstein, N., Chambers, B., Cote, R., Lebrun, L., Pirisi, A. and Norris, J. W. (2000) Seizures after stroke: a prospective multicenter study. Arch. Neurol. 57, 1617-1622.
136. Burn, J., Dennis, M., Bamford, J., Sandercock, P., Wade, D. and Warlow, C. (1997) Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 315, 1582-1587.
137. So, E. L., Annegers, J. F., Hauser, W. A., O'Brien, P. C. and Whisnant, J. P. (1996) Population-based study of seizure disorders after cerebral infarction. Neurology 46, 350-355.
138. Ferro, J. M., Correia, M., Rosas, M. J., Pinto, A. N. and Neves, G. (2003) Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc. Dis. 15, 78-83.
139. Annegers, J. F., Hauser, W. A., Beghi, E., Nicolosi, A. and Kurland, L. T. (1988) The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38, 1407-1410.
140. Hesdorffer, D. C., Logroscino, G., Cascino, G., Annegers, J. F. and Hauser, W. A. (1998) Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann. Neurol. 44, 908-912.
141. Pitkanen, A. and Halonen, T. (1998) Prevention of epilepsy. Trends Pharmacol. Sci. 19, 253-255.
142. Pitkanen, A. and McIntosh, T. K. (2006) Animal models of post-traumatic epilepsy. J. Neurotrauma 23, 241-261.
143. Kharatishvili, I., Nissinen, J. P., McIntosh, T. K. and Pitkanen, A. (2006) A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140, 685-697.
144. Karhunen, H., Jolkkonen, J., Sivenius, J. and Pitkanen, A. (2005) Epileptogenesis after experimental focal cerebral ischemia. Neurochem. Res. 30, 1529-1542.
145. BenAri, Y. (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14, 375-403.
146. Olney, J. W., de Gubareff, T. and Labruyere, J. (1983) Seizure-related brain damage induced by cholinergic agents. Nature 301, 520-522.
147. Turski, L., Cavalheiro, E. A., Sieklucka-Dziuba, M., Ikonomidou-Turski, C., Czuczwar, S. J. and Turski, W. A. (1986) Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res. 398, 37-48.
148. Nissinen, J., Halonen, T., Koivisto, E. and Pitkanen, A. (2000) A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat. Epilepsy Res. 38, 177-205.
149. Lothman, E. W., Bertram, E. H., Kapur, J. and Stringer, J. L. (1990) Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res. 6, 110-118.
150. Mazarati, A. M., Wasterlain, C. G., Sankar, R. and Shin, D. (1998) Self-sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Res. 801, 251-253.
151. Hellier, J. L., Patrylo, P. R., Dou, P., Nett, M., Rose, G. M. and Dudek, F. E. (1999) Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment. J. Neurosci. 19, 10053-10064.
152. Cavalheiro, E. A., Riche, D. A. and Le Gal, L. S. (1982) Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr. Clin. Neurophysiol. 53, 581-589.
153. Cavalheiro, E. A., Leite, J. P., Bortolotto, Z. A., Turski, W. A., Ikonomidou, C. and Turski, L. (1991) Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32, 778-782.
154. Klitgaard, H., Matagne, A., Vanneste-Goemaere, J. and Margineanu, D. G. (2002) Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res. 51, 93-107.
155. Mathern, G. W., Bertram, E. H., III, Babb, T. L., Pretorius, J. K., Kuhlman, P. A., Spradlin, S. and Mendoza, D. (1997) In contrast to kindled seizures, the frequency of spontaneous epilepsy in the limbic status model correlates with greater aberrant fascia dentata excitatory and inhibitory axon sprouting, and increased staining for N-methyl-D-aspartate, AMPA and GABA(A) receptors. Neuroscience 77, 1003-1019.
156. Gorter, J. A., van Vliet, E. A., Aronica, E. and Lopes da Silva, F. H. (2001) Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur. J. Neurosci. 13, 657-669.
157. Holtkamp, M., Matzen, J., van Landeghem, F., Buchheim, K. and Meierkord, H. (2005) Transient loss of inhibition precedes spontaneous seizures after experimental status epilepticus. Neurobiol. Dis. 19, 162-170.
158. Kelly, K. M., Kharlamov, A., Hentosz, T. M., Kharlamova, E. A., Williamson, J. M., Bertram, E. H., III, Kapur, J. and Armstrong, D. M. (2001) Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats. Epilepsy Res. 47, 189-203.
159. Kharlamov, E. A., Jukkola, P. I., Schmitt, K. L. and Kelly, K. M. (2003) Electrobehavioral characteristics of epileptic rats following photothrombotic brain infarction. Epilepsy Res. 56, 185-203.
160. Liu, J., Schmitt, K. L., Kharlamov, E. A., Stolarski, C. J., Grayson, D. R. and Kelly, K. M. (2002) Quantitative reverse transcription-polymerase chain reaction of GABA(A) alpha1, beta1 and gamma2S subunits in epileptic rats following photothrombotic infarction of neocortex. Epilepsy Res. 52, 85-95.
161. Kelly, K. M. (2006) Stroke. In: Animal Models of Epilepsy, pp. 501-520, Pitkanen, A., Moshe, S. L. and Schwartzkroin, P. A. (eds.), Elsevier Academic Press, London.
162. Shirasaka, Y. and Wasterlain, C. G. (1994) Chronic epileptogenicity following focal status epilepticus. Brain Res. 655, 33-44.
163. Gorter, J. A., van Vliet, E. A., Aronica, E. and Lopes da Silva, F. H. (2002) Long-lasting increased excitability differs in dentate gyrus vs. CA1 in freely moving chronic epileptic rats after electrically induced status epilepticus. Hippocampus 12, 311-324.
164. Kobayashi, M. and Buckmaster, P. S. (2003) Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J. Neurosci. 23, 2440-2452.
165. Cohen, A. S., Lin, D. D., Quirk, G. L. and Coulter, D. A. (2003) Dentate granule cell GABA(A) receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur. J. Neurosci. 17, 1607-1616.
166. Leroy, C., Poisbeau, P., Keller, A. F. and Nehlig, A. (2004) Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J. Physiol 557, 473-487.
167. Mazarati, A. M. and Wasterlain, C. G. (1997) Blockers of NMDA receptor restore paired-pulse inhibition in the rat dentate gyrus lesioned by perforant path stimulation. Neurosci. Lett. 234, 135-138.
168. Heinemann, U., Beck, H., Dreier, J. P., Ficker, E., Stabel, J. and Zhang, C. L. (1992) The dentate gyrus as a regulated gate for the propagation of epileptiform activity. Epilepsy Res. Suppl. 7, 273-280.
169. Lothman, E. W., Stringer, J. L. and Bertram, E. H. (1992) The dentate gyrus as a control point for seizures in the hippocampus and beyond. Epilepsy Res. Suppl. 7, 301-313.
170. Behr, J., Gloveli, T., Gutierrez, R. and Heinemann, U. (1996) Spread of low Mg2+ induced epileptiform activity from the rat entorhinal cortex to the hippocampus after kindling studied in vitro. Neurosci. Lett. 216, 41-44.
171. Schwarzer, C., Tsunashima, K., Wanzenbock, C., Fuchs, K., Sieghart, W. and Sperk, G. (1997) GABA(A) receptor subunits in the rat hippocampus II: altered distribution in kainic acid-induced temporal lobe epilepsy. Neuroscience 80, 1001-1017.
172. Brooks-Kayal, A. R., Shumate, M. D., Jin, H., Rikhter, T. Y. and Coulter, D. A. (1998) Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat. Med. 4, 1166-1172.
173. Fritschy, J. M., Kiener, T., Bouilleret, V. and Loup, F. (1999) GABAergic neurons and GABA(A)-receptors in temporal lobe epilepsy. Neurochem. Int. 34, 435-445.
174. Davenport, C. J., Brown, W. J. and Babb, T. L. (1990) Sprouting of GABAergic and mossy fiber axons in dentate gyrus following intrahippocampal kainate in the rat. Exp. Neurol. 109, 180-190.
175. Esclapez, M. and Houser, C. R. (1999) Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. J. Comp. Neurol. 412, 488-505.
176. Cavazos, J. E., Zhang, P., Qazi, R. and Sutula, T. P. (2003)
177. Wuarin, J. P. and Dudek, F. E. (1996) Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J. Neurosci. 16, 4438-4448.
178. Okazaki, M. M., Molnar, P. and Nadler, J. V. (1999) Recurrent mossy fiber pathway in rat dentate gyrus: synaptic currents evoked in presence and absence of seizure-induced growth. J. Neurophysiol. 81, 1645-1660.
179. Feng, L., Molnar, P. and Nadler, J. V. (2003) Short-term frequency-dependent plasticity at recurrent mossy fiber synapses of the epileptic brain. J. Neurosci. 23, 5381-5390.
180. Longo, B. M. and Mello, L. E. (1997) Blockade of pilocarpineor kainate-induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci. Lett. 226, 163-166.
181. Longo, B. M. and Mello, L. E. (1998) Supragranular mossy fiber sprouting is not necessary for spontaneous seizures in the intrahippocampal kainate model of epilepsy in the rat. Epilepsy Res. 32, 172-182.
182. Labiner, D. M., Butler, L. S., Cao, Z., Hosford, D. A., Shin, C. and McNamara, J. O. (1993) Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J. Neurosci. 13, 744-751.
183. Watanabe, Y., Johnson, R. S., Butler, L. S., Binder, D. K., Spiegelman, B. M., Papaioannou, V. E. and McNamara, J. O. (1996) Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J. Neurosci. 16, 3827-3836.
184. Sutula, T., Koch, J., Golarai, G., Watanabe, Y. and McNamara, J. O. (1996) NMDA receptor dependence of kindling and mossy fiber sprouting: evidence that the NMDA-receptor regulates patterning of hippocampal circuits in the adult brain. J. Neurosci. 16, 7398-7406.
185. Bonislawski, D. P., Schwarzbach, E. P. and Cohen, A. S. (2007) Brain injury impairs dentate gyrus inhibitory efficacy. Neurobiol. Dis. 25, 163-169.
186. Slapo, G. D., Lossius, M. I. and Gjerstad, L. (2006) Poststroke epilepsy: occurrence, predictors and treatment. Expert. Rev Neurother. 6, 1801-1809.
187. Camilo, O. and Goldstein, L. B. (2004) Seizures and epilepsy after ischemic stroke. Stroke 35, 1769-1775.
188. Pitkanen, A., Kharatishvili, I., Narkilahti, S., Lukasiuk, K. and Nissinen, J. (2005) Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res. 63, 27-42.
189. Suchomelova, L., Baldwin, R. A., Kubova, H., Thompson, K. W., Sankar, R. and Wasterlain, C. G. (2006) Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatr. Res. 59, 237-243.
190. Francois, J., Koning, E., Ferrandon, A. and Nehlig, A. (2006) The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 72, 147-163.
191. Andre, V., Rigoulot, M. A., Koning, E., Ferrandon, A. and Nehlig, A. (2003) Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 44, 893-903.
192. Brandt, C., Potschka, H., Loscher, W. and Ebert, U. (2003) Nmethyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118, 727-740.
193. Bolanos, A. R., Sarkisian, M., Yang, Y., Hori, A., Helmers, S. L., Mikati, M., Tandon, P., Stafstrom, C. E. and Holmes, G. L. (1998) Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51, 41-48.
194. Brandt, C., Gastens, A. M., Sun, M., Hausknecht, M. and Loscher, W. (2006) Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51, 789-804.
195. Capella, H.M. and Lemos, T. (2002) Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy. Epilepsia 43 Suppl. 5, 110-111.
196. Halonen, T., Nissinen, J. and Pitkanen, A. (2001) Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat. Epilepsy Res. 46, 205-223.
197. Halonen, T., Nissinen, J. and Pitkanen, A. (2001) Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats. Neuropharmacology 40, 536-550.
198. Andre, V., Ferrandon, A., Marescaux, C. and Nehlig, A. (2001)Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 47, 99-117.
199. Hort, J., Brozek, G., Mares, P., Langmeier, M. and Komarek, V. (1999) Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia 40, 1177-1183.
200. Klitgaard, H., Matagne, A., Vanneste-Goemaere, J. and Margineanu, D. G. (2001) Effects of prolonged administration of levetiracetam on pilocarpine-induced epileptogenesis in rat. Epilepsia 42 Suppl. 7, 114-115 (abstract).
201. Temkin, N. R. (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42, 515-524.
202. Mamelle, N., Mamelle, J. C., Plasse, J. C., Revol, M. and Gilly, R. (1984) Prevention of recurrent febrile convulsions - a randomized therapeutic assay: sodium valproate, phenobarbital and placebo. Neuropediatrics 15, 37-42.
203. Camfield, P. R., Camfield, C. S., Shapiro, S. H. and Cummings, C. (1980) The first febrile seizure-antipyretic instruction plus either phenobarbital or placebo to prevent recurrence. J. Pediatr. 97, 16-21.
204. Thilothammal, N., Kannan, Krishnamurthy, P. V., Kamala, K. G., Ahamed, S. and Banu, K. (1993) Role of phenobarbitone in preventing recurrence of febrile convulsions. Indian Pediatr. 30, 637-642.
205. Wolf, S. M., Carr, A., Davis, D. C., Davidson, S., Dale, E. P., Forsythe, A., Goldenberg, E. D., Hanson, R., Lulejian, G. A., Nelson, M. A., et al. (1977) The value of phenobarbital in the child who has had a single febrile seizure: a controlled prospective study. Pediatrics 59, 378-385.
206. White, N. J. (1998) Notmuch progress in treatment of cerebral malaria. Lancet 352, 594-595.
207. D'Onofrio, G., Rathlev, N. K., Ulrich, A. S., Fish, S. S. and Freedland, E. S. (1999) Lorazepam for the prevention of recurrent seizures related to alcohol. N. Engl. J. Med. 340, 915-919.
208. Lee, S., T., Lui, T., N., Chang, C. N., Cheng, W. C., Wang, D. J., Heimburger, R. F. and Lin, C. G. (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg. Neurol. 31, 361-364.
209. North, J. B., Penhall, R. K., Hanieh, A., Frewin, D. B. and Taylor, W. B. (1983) Phenytoin and postoperative epilepsy. A double-blind study., J. Neurosurg. 58, 672-677.
210. Temkin, N. R., Dikmen, S. S., Wilensky, A. J., Keihm, J., Chabal, S. and Winn, H. R. (1990) A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N. Engl. J. Med. 323, 497-502.
211. Dodson, W. E. (2004) Definitions and classification of epilepsy. In: The Treatment of Epilepsy, pp. 3-20, Shorvon, S., Perucca, E., Fish, D. and Dodson, E. (eds.), Blackwell Publishing, Oxford.
212. Jennett, W. B. (1962) Epilepsy after Blunt Head Injuries, William Heinemann Medical Books, London.
213. Schierhout, G. and Roberts, I. (2001) Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst. Rev. CD000173.
214. Sander, J. W. (2003) The epidemiology of epilepsy revisited. Curr. Opin. Neurol. 16, 165-170.
215. Kwan, P. and Brodie, M. J. (2000) Early identification of refractory epilepsy., N. Engl., J. Med. 342, 314-319.
216. Remy, S. and Beck, H. (2006) Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129, 18-35.
217. Sisodiya, S. M. (2003) Mechanisms of antiepileptic drug resistance. Curr. Opin. Neurol. 16, 197-201.
218. Loscher, W., Poulter, M. O. and Padjen, A. L. (2006) Major targets and mechanisms of antiepileptic drugs and major reasons for failure. Adv. Neurol. 97, 417-427.
219. Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22, 489-501.
220. Doman, G. and Pelligra, R. (2003) Ictogenesis: the origin of seizures in humans. A new look at an old theory. Med. Hypotheses 60, 129-132.
221. Lerche, H., Jurkat-Rott, K. and Lehmann-Horn, F. (2001) Ion channels and epilepsy. Am. J. Med. Genet. 106, 146-159.
222. Chen, K., Aradi, I., Thon, N., Eghbal-Ahmadi, M., Baram, T. Z. and Soltesz, I. (2001) Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat. Med. 7, 331-337.
223. Bernard, C., Anderson, A., Becker, A., Poolos, N. P., Beck, H. and Johnston, D. (2004) Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305, 532-535.
224. Su, H., Sochivko, D., Becker, A., Chen, J., Jiang, Y., Yaari, Y. and Beck, H. (2002) Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J. Neurosci. 22, 3645-3655.
225. Giaretta, D., Avoli, M. and Gloor, P. (1987) Intracellular recordings in pericruciate neurons during spike and wave discharges of feline generalized penicillin epilepsy. Brain Res. 405, 68-79.
226. Engel, J., Jr., Dichter, M. and Schwartzkroin, P. A. (1997) Basic mechanisms of human epilepsy. In: Epilepsy: A Comprehensive Textbook, pp. 499-512, Engel, J., Jr. and Pedley, T., A. (eds.), Lippincott-Raven, Philadelphia.
227. Holtkamp, M., Buchheim, K., Siegmund, H. and Meierkord, H. (2003) Optical imaging reveals reduced seizure spread and propagation velocities in aged rat brain in vitro. Neurobiol. Aging 24, 345-353.
228. Buchheim, K., Schuchmann, S., Siegmund, H., Weissinger, F., Heinemann, U. and Meierkord, H. (2000) Comparison of intrinsic optical signals associated with low Mg2+-and 4-aminopyridine-induced seizure-like events reveals characteristic features in adult rat limbic system. Epilepsia 41, 635-641.
229. Salek-Haddadi, A., Merlet, I., Mauguière, F., Meierkord, H., Buchheim, K., Fish, D., Koepp, M. J. and So, E. L. (2004) New physiological and radiological interventions in the presurgical evaluation of epilepsy. In: The Treatment of Epilepsy, pp. 665-698, Shorvon, S., Perucca, E., Fish, D. and Dodson, E. (eds.), Blackwell Publishing, Oxford.
230. During, M. J. and Spencer, D. D. (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 32, 618-624.
231. Kostopoulos, G., Drapeau, C., Avoli, M., Olivier, A. and Villemeure, J. G. (1989) Endogenous adenosine can reduce epileptiform activity in the human epileptogenic cortex maintained in vitro. Neurosci. Lett. 106, 119-124.
232. Engel, J., Jr., Kuhl, D. E., Phelps, M. E., Rausch, R. and Nuwer, M. (1983) Local cerebral metabolism during partial seizures. Neurology 33, 400-413.
233. Engel, J., Jr., Lubens, P., Kuhl, D. E. and Phelps, M. E. (1985) Local cerebral metabolic rate for glucose during petit mal absences. Ann. Neurol. 17, 121-128.
234. Loscher, W. (2002) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50, 105-123.
235. Sato, M., Racine, R. J. and McIntyre, D. C. (1990) Kindling: basic mechanisms and clinical validity. Electroencephalogr. Clin. Neurophysiol. 76, 459-472.
236. Stables, J. P., Bertram, E., Dudek, F. E., Holmes, G., Mathern, G., Pitkanen, A. and White, H. S. (2003) Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 44, 1472-1478.
237. Nissinen, J. and Pitkanen, A. (2007) Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. Epilepsy Res. 73, 181-191.
238. McDonagh, J., Stephen, L. J., Dolan, F. M., Parks, S., Dutton, G. N., Kelly, K., Keating, D., Sills, G. J. and Brodie, M. J. (2003) Peripheral retinal dysfunction in patients taking vigabatrin. Neurology 61, 1690-1694.
239. Koepp, M. J., Edwards, M., Collins, J., Farrel, F. and Smith, S. (2005) Status epilepticus and tiagabine therapy revisited. Epilepsia 46, 1625-1632.
240. Sohal, V. S., Keist, R., Rudolph, U. and Huguenard, J. R. (2003) Dynamic GABA(A) receptor subtype-specific modulation of the synchrony and duration of thalamic oscillations. J. Neurosci. 23, 3649-3657.
241. Subramaniam, S., Rho, J. M., Penix, L., Donevan, S. D., Fielding, R. P. and Rogawski, M., A. (1995) Felbamate block of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 273, 878-886.
242. Troupin, A. S., Mendius, J. R., Cheng, F. and Risinger, M. W. (1986) MK-801. In: New Anticonvulsant Drugs, pp. 191-201, Meldrum, B., S. and Porter, R., J. (eds.), John Libbey, London.
243. Chappell, A. S., Sander, J. W., Brodie, M. J., Chadwick, D., Lledo, A., Zhang, D., Bjerke, J., Kiesler, G. M. and Arroyo, S. (2002) A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology 58, 1680-1682.